Alzheimer 
Introduction
Alzheimer's disease (AD) is the chief cause of dementia. 1 It is a systemic disorder whose major manifestations are in the brain. [2] [3] [4] The majority of cases 5 (90-95 percent) are sporadic (SAD). The remaining 5-10 percent are familial (FAD). 5 Most FAD cases are caused by mutations in the gene for presenilin 1 (PS1) on chromosome 14, 5, 6 some by mutations in the gene for presenilin 2 (PS2) on chromosome 1, 7 while a few have mutations in the gene for the amyloid precursor protein (APP) on chromosome 21. 7, 8 AD is characterized by intraneuronal fibrillary tangles, plaques, and cell loss; 1, 2, [9] [10] [11] [12] major steps in pathogenesis have been summarized. 4 Plaques contain βA peptides (mainly βA42), formed by proteolysis of APP, that have aggregated into fibrils. Most peptides are in plaques that are not recognized by the usual Congo red and thioflavin methods, i.e., preamyloid plaques-also termed diffuse or amorphous plaques. The minor peptide fraction, formed by the action of free radicals on the fibrillary form of the βA peptide present in preamyloid, 13 is in plaques recognized by Congo red, i.e. amyloid plaques. Amyloid formation is generally associated with the clinical manifestations of AD. The brain lesions in both SAD and FAD are the same, and in the same distribution pattern, as those seen in individuals with Down' s syndrome (DS), 1, 14 and in smaller numbers in non-demented older individuals. 15, 16 Dementia onset is around age 40 for Down's syndrome, 14 40-60 years for FAD, 5 and usually 60 years for SAD. 5 Lower dementia onset ages are associated with shorter life spans. Extensive studies of AD have yet to result in a generally accepted hypothesis on pathogenesis. [17] [18] [19] [20] Major emphasis has been placed on the role of amy-loid, [19] [20] [21] [22] [23] [24] the neurotoxin formed by the action of free radicals on preamyloid.
12,13
Hypothesis on Pathogenesis of Alzheimer's Disease
The frequent presence of AD lesions in normal older persons, coupled with the association between lower dementia onset ages and shorter life spans, prompted the hypothesis that the different categories of AD are the result of processes which augment to different degrees the innate cellular aging rate, i.e., mitochondrial superoxide radical (SO) formation. Thus, they increase the rate of accumulation of AD lesions. This lowers the age of onset of the dementia of old age into the dementia ranges associated with Down' s syndrome, FAD, and SAD, and concomitantly, shorten life spans.
Aging
Aging is the accumulation of diverse deleterious changes in the cells and tissues that increase the risk of disease and death. 25, 26 Many theories have been advanced to account for aging. No theory is generally accepted. The Free Radical Theory of Aging 27, 28 (FRTA) is a promising hypothesis; the subsequent discussion is based on the assumption that it is correct. The FRTA postulates that aging changes are caused by free radical reactions. Those responsible for the innate cellular aging process largely stem from the superoxide radicals (SO) formed by the mitochondria at an increasing rate with age in the course of normal metabolism. These, plus the free radicals arising from suboptimal living conditions, 29 cause "aging".
Involvement of the Aging process in Formation of the Characteristic Lesions of AD Intraneuronal Fibrillary Tangles: The latter permits phosphorylated tau to selfassemble and form paired helical filaments and, in turn neurofibrillary tangles, while concomitantly the destabilized microtubules breakdown. Cells with neurofibrillary tangles eventually die.
Neuritic plaques. The progresive increase in cellular superoxide radical formation with age 30, 31 AD should be reflected in rising intercellular levels of H2O2 in the brain. At some age and in some locations, these levels could begin to exceed the threshold for the activation of microglia cells in a manner akin to the up-regulation of the synthesis of cytokines IL-8 and TNF-α by dendritic cells. 32 Then, free radicals formed by activated microglia could serve to catalyze the oxidative conversion of preamyloid in the microglia area to amyloid, and simultaneously initiate the inflammation1 9,33 involved in neuritic plaque formation and neuronal cell loss.
Thus, increasing mitochondria superoxide radical production lowers AD onset age by decreasing the onset age of AD lesions. How apolipoprotein E4 lowers AD onset age is not known. The O2 mediated interaction between ApoE4 34 and βA4 suggests a possible explanation: Reaction of tissue O2 with ApoE4 may serve as a catalyst for the slow oxidative compaction of preamyloid, a process which results eventually in formation of amyloid. Thus, when H2O2-induced microglia activation occurs, less time is required to complete the compaction. Hence, the age of onset of clinical symptoms of AD is decreased, more so the longer the period of ApoE4-associated compaction.
Augmentation of the Innate Aging Rate
Sporadic AD: Increases in mitochondrial SO formation in SAD is attributed 4 to accumulating free radical-induced mutation(s) in one or more of the approximately 1000 mtDNA and nucDNA genes involved in mitochondrial biogenesis and function. 35 This should decrease the age when the normally accumulating AD lesions increase into the AD dementia onset ages associated with SAD, and concomitantly, shortens life span.
In view of the above it is not surprising that efforts to find the gene(s) responsible for sporadic AD have been inconclusive. 19, [36] [37] [38] This disorder could be initiated by one or more of a large number of combinations of mutations of the genes associated with mitochondrial function, e.g., those influencing cytochrome oxidase. 39 Identification of the initiating mutation(s) would be expected to be made progressively more difficult with time by the continuing accumulation of mutations throughout life.
Familial AD: APP, PS1, and PS2, as well as their mutated forms, undergo proteolytic processing in the endoplasmic reticulum (ER) membrane. 19 These compounds are ubiquitously expressed transmembrane proteins; APP has a single transmembrane domain while PS1 and PS2 have six to nine. 40 The turnover time of normal APP is short (20-30 minutes). 40, 41 Turnover times of PS1 and PS2 are also short, about 15 minutes; 42 that of the complex formed from the N-and C-terminal fragments is apparently greater than 12 hours. 43 Mutations in the APP and the presenilins should further shorten turnover times. 44 Cleavage of APP by α-or β-secretase produces, respectively, membrane-bound 83-and 99-residue C-terminal fragments. These fragments are cleaved by γ-secretase, apparently formed 45 from the N-and C-terminal fragments of either PS1 or PS2; the products of the C99 cleavage include the ßA40 and ßA42 peptides. Mutants of the presenilins increase the fraction of ßA42, 19 and increase it further with mutated APP. 19 The calcium buffering activity of the ER is modulated by the ATPase calcium pumps, It seems very likely that mutations in APP or the presenilins decrease ER calcium buffering, in a manner akin to that of one or more of the substances known to influence it, resulting in compensatory increases in other calcium pools, particularly in mitochondria. The foregoing is strongly supported by studies with cultured neurons. [60] [61] [62] Increases in mitochondrial calcium content enhances superoxide radical formation, 63 and in turn, lowers the AD onset age.
Clinical manifestations of FAD, and death, occur at significantly lower ages than for those with SAD. This can be attributed to a combination of one or more of the following: 1) Mitochondrial superoxide radical formation is increased secondary to the increased O2 consumption associated with increased turnover of the mutated forms of APP and of the presenilins; 2) Increased formation of the more amyloidogenic forms of Aß, i.e, Aß42; 3) Down-regulation of the calcium buffering activity of the ER leading to increased mitochondrial superoxide radical formation; 4) Amyloid-associated inflammatory responses.
Down's Syndrome (DS)
Individuals with this disorder have three copies of chromosome 21 rather than the normal two. Chromosome 21 codes for both superoxide dismutase (SOD) and APP; these gene products are increased in the cells of individuals with DS. 64 Persons with this disorder display premature aging; 64, 65 manifestations include rapid aging of the skeletal system and skin, early menopause, short life span, and AD-like pathology 14 after about age 40. The first indication of the latter is generally apathy 64 and recent memory loss. 66 The early onset of AD in individuals with Down' s syndrome is attributed to an enhanced rate of neuronal SO formation; 67, 68 probably a result of a defect in complex 1 of the respiratory chain. 67 Thus, the early appearance of AD in individuals with Down's syndrome, as with SAD and FAD, may be largely caused by a higher than normal rate of increase with age of SO.
Dementia Pugilistica (DP): An AD Related Disorder A blow(s) to the head is a risk factor for Alzheimer's disease. 69 Repeated blows are associated with DP -the punch drunk syndrome. 70, 71 The severity of the syndrome correlates with the length of the boxing career and total number of bouts, and has an overall incidence of about 17% in professional boxers which rises with age. 70, 71 There are numerous neurofibrillary tangles in the cerebral cortex, particularly in the temporal lobe. 70, 71 In contrast to AD, neuritic plaques are few while diffuse preamyloid plaques 70 are abundant; the diffuse plaques can form within days after head injury. 72 Most cases show evidence of past brain hemorrhage. 73 The initiating steps in pathogenesis of DP may be similar to those of sporadic AD. Extracellular iron, e.g., in the form of heme, may disrupt calcium homeostasis by increasing the influx of calcium through the neuronal membrane by: 1) catalyzing oxidative alterations in the membrane, and 2) increasing intracellular H2O2 concentrations (by catalyzing the aggregation rate of extracellular ßA peptides to form amyloid, this in turn perturbs the neuronal membrane so as to activate an NADPH oxidase 74 ). Increasing neuronal calcium concentration in the foregoing manner should result in neurofibrillary tangle formation. 4 The relative paucity of neuritic plaques in boxers is probably because their brain intercellular levels of H2O2, like those of the average person, are below the level needed to induce activation of microglial cells.
Comment
The brain lesions of SAD, FAD, those seen after about age 40 in individuals with Down's syndrome, and in older non-demented persons, are the same and have the same distribution, but differ in the age of onset and the degree of involvement. The foregoing prompted the hypothesis that the different categories of AD are the result of processes ( Table 1 , below) which augment to different degrees the innate cellular aging rate, i.e., rate of mitochondrial SO formation. These lower AD dementia onset ages to those associated with Down' s syndrome, FAD, and SAD, and concomitantly, shortens life spans. Table 1 . Processes which augment to different degrees the innate cellular aging process, i.e., mitochondrial superoxide radical formation, lower the age when the normally accumulating AD lesions increase into the dementia ranges associated with SAD, FAD, and Down's syndrome.
AD category Processes
SAD: Accumulation of free radical-induced mutation(s) in one or more of the approximately 1000 mtDNA and nucDNA genes involved in mitochondrial biogenesis and function.
FAD: Mutations in APP or the presenilins that down-regulate ER calcium buffering capacity. This increases mitochondrial calcium levels resulting in enhanced SO formation.
DS:
Defective complex 1 of the mitochondrial respiratory chain.
The age of the appearance of neurofibrillary tangles and of that for neuritic plaques are not necessarily the same. The innate aging process serves as the final common pathway for AD.
The hypothesis suggests practical measures to prevent and treat. 4, 75, 76 Thus the age of onset of all categories of AD may be increased by measures to delay conversion of preamyloid to amyloid, e.g., minimize the expected rise of tissue H2O2 in the brain with age using compounds such as lipoic acid or dehydroascorbic acid. 75, 76 
